Castillo, Rusil T.

HRN: 27-35-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 500MG (TAB)
06/22/2025
06/27/2025
PO
500mg
BID
NSVD WITH RMLE
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines